Information about Bard IVC Filter Lawsuits from Lawyers Handling IVC Filter Lawsuits

No-Cost, No-Obligation Bard IVC Filter Lawsuit Review

IVC Filter Lawsuits

Thousands Of IVC Filters May Eventually Experience Catastrophic Failure

Bard IVC Filter Lawsuits

A five percent IVC failure designation seems acceptable on the surface, but not for the thousands of people whose lives are at risk

Thursday, September 2, 2021 - Numerous models of IVC filters have failed but according to adverse event reports certain brands are more deadly than others. More than 81,000 IVC filter devices have been recalled in total during the period 2005 - 2015, according to DrugWatch.com. An FDA Bard IVC Filter Warning resulted in more than 1000 Bard Denali IVC filters being recalled in March of 2015. The Food and Drug Administration has issued Class I recalls, the type of designation reserved for medical devices that could cause death, for several types of IVC filters. The Bard Denali IVC filter received a Class II recall suggesting the complications are less severe. In reality, the injuries that Bard IVC filter patients have reported may warrant a more restrictive classification. Lawsuits filed against Bard allege that the defective design of the filters makes their brand more likely to fracture, migrate, tilt or perforate the inferior vena cava and cause permanent damage to the lungs or heart, possibly ending in death. Bard IVC filter lawyers are interviewing those who have had revision surgery to remove the defective Bard filters.

Some of the more optimistic studies indicate that the device is generally safe to use. Catastrophic failure could occur in five percent or more of patients that have the implant. Successful retrieval of an IVC filter is essential when comparing success rates among the various types of medical devices. An IVC filter should remain in place only when the patient is at risk for blood clots. Physicians published in the National Institute of Health (NIH) say, "Retrievable filters warrant consideration in patients who meet high-risk criteria for deep vein thrombosis or pulmonary embolism (PE) who cannot receive effective mechanical prophylaxis and in whom contraindications to anticoagulation are expected to be temporary." Radiology Info.com explains that not all IVC filters should be removed if the risks have not passed, and may be left in place permanently. Physicians that recommend the Bard IVC filters may be ignoring the risks inherent in leaving the device in place for more than a few weeks. Scar tissue can develop and permanently encase the filter wherever it is and make its retrieval impossible without major, invasive surgery to remove a section of the artery. The device can fracture during the removal process sending metal pieces free to travel and puncture the artery, lungs, or heart. What the studies fail to address is the high percentage of IVC surgeons who recommend that a temporary filter remains in place permanently because they are unwilling to attempt to retrieve it. An article written by Sandip Bhattacharays, owner of Alivio Healthcare, tells readers that it is just a matter of time before all IVC filters eventually fail. He tells Linked in readers, "According to some experts, there is a very high failure rate with these devices, which only increases with the duration of the filter in the body, eventually, all of the devices will fail. So 100% failure of the device becomes not a question of if but when."

More Recent IVC Filter Lawsuit News:

No-Cost, No-Obligation Bard IVC Filter Lawsuit Case Review for Persons or Families of Persons Who Suffered from Organ Damage, Severe Bleeding, Stroke, or Death

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation.